|
EP1558645B1
(en)
|
2002-11-08 |
2011-07-27 |
Ablynx N.V. |
Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
|
|
EP1900753B1
(en)
|
2002-11-08 |
2017-08-09 |
Ablynx N.V. |
Method of administering therapeutic polypeptides, and polypeptides therefor
|
|
WO2004041863A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Single domain antibodies directed against interferon- gamma and uses therefor
|
|
ATE485307T1
(de)
|
2003-11-07 |
2010-11-15 |
Ablynx Nv |
Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung
|
|
GB0507044D0
(en)
*
|
2005-04-06 |
2005-05-11 |
Celltech R&D Ltd |
Primers
|
|
GB0507046D0
(en)
*
|
2005-04-06 |
2005-05-11 |
Celltech R&D Ltd |
Primers
|
|
US8188223B2
(en)
|
2005-05-18 |
2012-05-29 |
Ablynx N.V. |
Serum albumin binding proteins
|
|
ES2694247T3
(es)
|
2005-05-20 |
2018-12-19 |
Ablynx N.V. |
NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación
|
|
US20100226920A1
(en)
*
|
2006-03-27 |
2010-09-09 |
Ablynx N.V. |
Medical delivery device for therapeutic proteins based on single domain antibodies
|
|
WO2008105886A2
(en)
*
|
2006-05-26 |
2008-09-04 |
Macrogenics, Inc. |
HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
|
|
CN101563365B
(zh)
*
|
2006-08-03 |
2012-10-31 |
瓦西尼斯公司 |
抗-il-6单克隆抗体及其用途
|
|
EP2073898A1
(en)
|
2006-10-10 |
2009-07-01 |
Academisch Ziekenhuis Bij De Universiteit Van Amsterdam |
Complement inhibition for improved nerve regeneration
|
|
EP2102244A2
(en)
|
2006-12-19 |
2009-09-23 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
|
|
CA2673331A1
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
|
PL2308514T3
(pl)
|
2007-03-23 |
2013-11-29 |
To Bbb Holding B V |
Koniugaty do ukierunkowanego dostarczania leku poprzez barierę krew-mózg
|
|
AU2008270274B2
(en)
|
2007-07-03 |
2012-06-28 |
Ablynx N.V. |
Providing improved immunoglobulin sequences by mutating CDR and/or FR positions
|
|
EP2650311A3
(en)
|
2007-11-27 |
2014-06-04 |
Ablynx N.V. |
Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
|
|
FR2924440B1
(fr)
|
2007-12-04 |
2015-01-09 |
Pf Medicament |
Nouveau procede de generation et de criblage d'une banque d'anticorps
|
|
EP2088432A1
(en)
*
|
2008-02-11 |
2009-08-12 |
MorphoSys AG |
Methods for identification of an antibody or a target
|
|
GB2470328A
(en)
|
2008-03-05 |
2010-11-17 |
Ablynx Nv |
Novel antigen binding dimer complexes, methods of making and uses thereof
|
|
JP2011516520A
(ja)
|
2008-04-07 |
2011-05-26 |
アブリンクス エン．ヴェー． |
Ｎｏｔｃｈ経路に指向性を有するアミノ酸配列及びその使用
|
|
WO2009127691A1
(en)
|
2008-04-17 |
2009-10-22 |
Ablynx N.V. |
Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
|
|
EP2285833B1
(en)
|
2008-05-16 |
2014-12-17 |
Ablynx N.V. |
AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
|
|
LT2285408T
(lt)
|
2008-06-05 |
2019-01-25 |
Ablynx N.V. |
Aminorūgščių sekos, nukreiptos prieš viruso apvalkalo baltymus, ir tokias sekas turintys polipeptidai, skirti virusinių ligų gydymui
|
|
WO2010010119A1
(en)
|
2008-07-22 |
2010-01-28 |
Ablynx Nv |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
|
CN102257003B
(zh)
|
2008-12-19 |
2017-04-05 |
埃博灵克斯股份有限公司 |
用于产生针对细胞相关抗原如p2x7、cxcr7或cxcr4的免疫球蛋白的基因免疫
|
|
US10005830B2
(en)
|
2009-03-05 |
2018-06-26 |
Ablynx N.V. |
Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
|
|
AU2010243551B2
(en)
|
2009-04-30 |
2015-03-26 |
Ablynx Nv |
Method for the production of domain antibodies
|
|
CA2758356C
(en)
|
2009-05-29 |
2016-07-26 |
Morphosys Ag |
A collection of vh and vl pairs having favourable biophysical properties and methods for its use
|
|
WO2011003622A1
(en)
|
2009-07-10 |
2011-01-13 |
Ablynx N.V. |
Method for the production of variable domains
|
|
LT2805731T
(lt)
|
2009-09-03 |
2019-02-11 |
Ablynx N.V. |
Stabilios polipeptidų kompozicijos ir jų panaudojimas
|
|
US20120321640A1
(en)
|
2009-12-01 |
2012-12-20 |
Ablynx N.V. |
Von willebrand factor specific binding agents and uses thereof
|
|
EP3309176B1
(en)
|
2009-12-14 |
2025-10-01 |
Ablynx N.V. |
Immunoglobulin single variable domain antibodies against ox40l, constructs and their therapeutic use
|
|
WO2011083140A1
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Immunoglobulin single variable domain directed against human cxcr4
|
|
EP2531523A1
(en)
|
2010-02-05 |
2012-12-12 |
Ablynx N.V. |
Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
|
|
US9120855B2
(en)
|
2010-02-10 |
2015-09-01 |
Novartis Ag |
Biologic compounds directed against death receptor 5
|
|
DK2533761T3
(da)
|
2010-02-11 |
2019-06-24 |
Ablynx Nv |
Fremgangsmåder og sammensætninger til fremstilling af aerosoler
|
|
EP2533814A2
(en)
|
2010-02-11 |
2012-12-19 |
Ablynx N.V. |
Delivery of immunoglobulin variable domains and constructs thereof
|
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
|
US9556273B2
(en)
|
2010-03-29 |
2017-01-31 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
|
EP2571901B1
(en)
|
2010-05-20 |
2019-01-02 |
Ablynx N.V. |
Biological materials related to her3
|
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
|
PL3279214T3
(pl)
|
2010-10-29 |
2025-03-24 |
Ablynx Nv |
Sposób wytwarzania pojedynczych domen zmiennych immunoglobuliny
|
|
US8367586B2
(en)
|
2010-11-19 |
2013-02-05 |
Morphosys Ag |
Collection and methods for its use
|
|
AU2012234282B2
(en)
|
2011-03-28 |
2015-07-16 |
Ablynx Nv |
Method for producing solid formulations comprising immunoglobulin single variable domains
|
|
UA117218C2
(uk)
|
2011-05-05 |
2018-07-10 |
Мерк Патент Гмбх |
Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
|
|
WO2012152823A1
(en)
|
2011-05-09 |
2012-11-15 |
Ablynx Nv |
Method for the production of immunoglobulin single variable domains
|
|
WO2012163887A1
(en)
|
2011-05-27 |
2012-12-06 |
Ablynx Nv |
Inhibition of bone resorption with rankl binding peptides
|
|
WO2012166906A1
(en)
|
2011-05-31 |
2012-12-06 |
Massachusetts Institute Of Technology |
Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
|
|
EP2723772A1
(en)
|
2011-06-23 |
2014-04-30 |
Ablynx N.V. |
Immunoglobulin single variable domains directed against ige
|
|
WO2013041722A1
(en)
|
2011-09-23 |
2013-03-28 |
Ablynx Nv |
Prolonged inhibition of interleukin-6 mediated signaling
|
|
JP6411333B2
(ja)
|
2012-05-24 |
2018-10-24 |
ブイアイビー ブイゼットダブリュＶｉｂ Ｖｚｗ |
腫瘍関連マクロファージのターゲティングおよびｉｎｖｉｖｏイメージング用抗マクロファージマンノース受容体単一可変ドメイン
|
|
US11339208B1
(en)
|
2012-05-31 |
2022-05-24 |
United States Of America As Represented By The Secretary Of The Air Force |
Camelidae single-domain antibodies against Yersinia pestis and methods of use
|
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
|
CN105102478A
(zh)
|
2013-01-30 |
2015-11-25 |
弗拉芒区生物技术研究所 |
用于筛选和药物发现目的的新型嵌合多肽
|
|
US20150368339A1
(en)
|
2013-02-05 |
2015-12-24 |
Vib Vzw |
Muscarinic acetylcholine receptor binding agents and uses thereof
|
|
JP6499090B2
(ja)
|
2013-03-15 |
2019-04-10 |
ブイアイビー ブイゼットダブリュＶｉｂ Ｖｚｗ |
心血管疾患において使用するための抗マクロファージマンノース受容体単一可変ドメイン
|
|
EP2992101B1
(en)
|
2013-04-29 |
2018-10-10 |
Agrosavfe N.V. |
Agrochemical compositions comprising antibodies binding to sphingolipids
|
|
NL1040254C2
(en)
|
2013-05-17 |
2014-11-24 |
Ablynx Nv |
Stable formulations of immunoglobulin single variable domains and uses thereof.
|
|
EP2883883A1
(en)
|
2013-12-16 |
2015-06-17 |
Cardio3 Biosciences S.A. |
Therapeutic targets and agents useful in treating ischemia reperfusion injury
|
|
US10233241B2
(en)
|
2014-01-30 |
2019-03-19 |
Vib Vzw |
Opioid receptor binding agents and uses thereof
|
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
|
DK3194976T3
(da)
|
2014-07-22 |
2020-07-13 |
Vib Vzw |
Fremgangsmåder til udvælgelse af midler, som stabiliserer proteinkomplekser
|
|
EP3718574A1
(en)
|
2014-07-29 |
2020-10-07 |
Vrije Universiteit Brussel |
Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer
|
|
WO2016016329A1
(en)
|
2014-07-29 |
2016-02-04 |
Vrije Universiteit Brussel |
Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response
|
|
US9938522B2
(en)
|
2014-09-25 |
2018-04-10 |
Genewiz, Inc. |
High throughput sequencing of end regions of long linear DNAs
|
|
US10858666B2
(en)
|
2014-11-05 |
2020-12-08 |
Biotalys |
Transgenic plants expressing a variable domain of a heavy chain antibody (VHH) that binds to a sphingolipid of a fungus
|
|
AU2015366284B2
(en)
|
2014-12-19 |
2021-07-22 |
Ablynx N.V. |
Cysteine linked nanobody dimers
|
|
MX390949B
(es)
|
2015-07-17 |
2025-03-21 |
Univ Brussel Vrije |
Fragmentos de anticuerpos radiomarcados para uso en tratamiento de cancer.
|
|
KR20180080337A
(ko)
|
2015-11-27 |
2018-07-11 |
아블린쓰 엔.브이. |
Ｃｄ40ｌ을 억제하는 폴리펩티드
|
|
US11243214B2
(en)
|
2016-04-22 |
2022-02-08 |
Université Libre de Bruxelles |
Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
|
WO2017182605A1
(en)
|
2016-04-22 |
2017-10-26 |
Université Libre de Bruxelles |
A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
|
CN109311968A
(zh)
|
2016-05-02 |
2019-02-05 |
埃博灵克斯股份有限公司 |
治疗rsv感染
|
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
|
US11098113B2
(en)
|
2016-09-15 |
2021-08-24 |
Vib Vzw |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
|
BR112019010061A2
(pt)
|
2016-11-16 |
2019-08-13 |
Ablynx Nv |
polipeptídeos de recrutamento de células t capazes de se ligarem ao cd123 e tcr alfa/beta
|
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
|
JP7186401B2
(ja)
|
2017-02-28 |
2022-12-09 |
フエー・イー・ベー・フエー・ゼツト・ウエー |
タンパク質の経口送達のための手段及び方法
|
|
US20200033347A1
(en)
|
2017-04-18 |
2020-01-30 |
Universite Libre De Bruxelles |
Biomarkers And Targets For Proliferative Diseases
|
|
KR20200005635A
(ko)
|
2017-05-11 |
2020-01-15 |
브이아이비 브이지더블유 |
가변 면역글로불린 도메인의 글리코실화
|
|
CN118894939A
(zh)
|
2017-06-02 |
2024-11-05 |
默克专利股份有限公司 |
结合adamts的免疫球蛋白
|
|
NZ759601A
(en)
|
2017-06-02 |
2023-06-30 |
Merck Patent Gmbh |
Aggrecan binding immunoglobulins
|
|
TW202417517A
(zh)
|
2017-06-02 |
2024-05-01 |
德商麥克專利有限公司 |
與ｍｍｐ１３結合之免疫球蛋白
|
|
JP7249961B2
(ja)
|
2017-06-02 |
2023-03-31 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ａｄａｍｔｓ５、ｍｍｐ１３およびアグリカンに結合するポリペプチド
|
|
CA3070253A1
(en)
|
2017-07-19 |
2019-01-24 |
Vib Vzw |
Serum albumin binding agents
|
|
KR20200091400A
(ko)
|
2017-10-31 |
2020-07-30 |
브이아이비 브이지더블유 |
신규한 항원-결합 키메라 단백질 및 이의 방법 및 용도
|
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
|
CA3092421A1
(en)
|
2018-03-01 |
2019-09-06 |
Vrije Universiteit Brussel |
Human pd-l1-binding immunoglobulins
|
|
IL277307B2
(en)
|
2018-03-23 |
2025-03-01 |
Univ Bruxelles |
Wnt signaling agonist molecules
|
|
CA3095080A1
(en)
|
2018-03-27 |
2019-10-03 |
Coen MAAS |
Targeted thrombolysis for treatment of microvascular thrombosis
|
|
WO2020221769A1
(en)
|
2019-04-29 |
2020-11-05 |
Confo Therapeutics N.V. |
Screening methods and assays for use with transmembrane proteins, in particular with gpcrs
|
|
EP3962599A1
(en)
|
2019-04-30 |
2022-03-09 |
Vib Vzw |
Cystic fibrosis transmembrane conductance regulator stabilizing agents
|
|
EP3976067A1
(en)
|
2019-05-28 |
2022-04-06 |
Vib Vzw |
Cd8+ t-cells lacking plexins and their application in cancer treatment
|
|
WO2020239945A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cancer treatment by targeting plexins in the immune compartment
|
|
WO2021078786A1
(en)
|
2019-10-21 |
2021-04-29 |
Vib Vzw |
Nanodisc-specific antigen-binding chimeric proteins
|
|
CA3160506A1
(en)
|
2019-11-11 |
2021-05-20 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
|
US20220411495A1
(en)
|
2019-11-27 |
2022-12-29 |
Vib Vzw |
Positive allosteric modulators of the calcium-sensing receptor
|
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
|
US20240027467A1
(en)
|
2019-12-20 |
2024-01-25 |
Vib Vzw |
Nanobody Exchange Chromatography
|
|
WO2021140205A1
(en)
|
2020-01-10 |
2021-07-15 |
Confo Therapeutics N.V. |
Methods for generating antibodies and antibody fragments and libraries comprising same
|
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
|
KR20230012464A
(ko)
|
2020-02-25 |
2023-01-26 |
브이아이비 브이지더블유 |
류신-풍부 반복 키나제 2 알로스테릭 조절제
|
|
WO2021198396A1
(en)
|
2020-03-31 |
2021-10-07 |
Biotalys NV |
Anti-fungal polypeptides
|
|
CN113527488B
(zh)
|
2020-04-22 |
2026-04-17 |
迈威(上海)生物科技股份有限公司 |
一种靶向人程序性死亡配体1（pd-l1）的单可变域抗体及其衍生物
|
|
WO2021229104A1
(en)
|
2020-05-15 |
2021-11-18 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
|
WO2022003156A1
(en)
|
2020-07-02 |
2022-01-06 |
Oncurious Nv |
Ccr8 non-blocking binders
|
|
WO2022023584A1
(en)
|
2020-07-31 |
2022-02-03 |
Biotalys NV |
Methods of increasing recombinant protein yields
|
|
WO2022063947A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Combination of p2y6 inhibitors and immune checkpoint inhibitors
|
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
|
AU2021350156A1
(en)
|
2020-09-25 |
2023-06-08 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and ox40l
|
|
WO2022117569A1
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
|
|
JP2024508207A
(ja)
|
2020-12-02 |
2024-02-26 |
ブイアイビー ブイゼットダブリュ |
がんに対する組み合わせ治療におけるｌｔｂｒアゴニスト
|
|
EP4263602A1
(en)
|
2020-12-18 |
2023-10-25 |
Ablynx N.V. |
Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf-alpha
|
|
GB202020502D0
(en)
|
2020-12-23 |
2021-02-03 |
Vib Vzw |
Antibody composistion for treatment of corona virus infection
|
|
EP4267621A1
(en)
|
2020-12-24 |
2023-11-01 |
Vib Vzw |
Murine cross-reactive human ccr8 binders
|
|
CA3206124A1
(en)
|
2020-12-24 |
2022-06-30 |
Vib Vzw |
Non-blocking human ccr8 binders
|
|
WO2022136647A1
(en)
|
2020-12-24 |
2022-06-30 |
Oncurious Nv |
Human ccr8 binders
|
|
IL304929A
(en)
|
2021-02-05 |
2023-10-01 |
Vib Vzw [Be/Be |
Sarbevirus binders
|
|
CN117794566A
(zh)
|
2021-02-05 |
2024-03-29 |
Vib研究所 |
沙贝病毒结合剂
|
|
WO2022175392A1
(en)
|
2021-02-17 |
2022-08-25 |
Vib Vzw |
Inhibition of slc4a4 in the treatment of cancer
|
|
EP4294516A1
(en)
|
2021-02-19 |
2023-12-27 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
|
CN117321076A
(zh)
|
2021-02-19 |
2023-12-29 |
美国卫生及公众服务部代表 |
中和SARS-CoV-2的单结构域抗体
|
|
WO2022199804A1
(en)
|
2021-03-24 |
2022-09-29 |
Vib Vzw |
Nek6 inhibition to treat als and ftd
|
|
US20240261446A1
(en)
|
2021-05-17 |
2024-08-08 |
Université de Liège |
Anti-cd38 single domain antibodies in disease monitoring and treatment
|
|
WO2022268993A1
(en)
|
2021-06-23 |
2022-12-29 |
Vib Vzw |
Means and methods for selection of specific binders
|
|
WO2023274183A1
(zh)
|
2021-06-29 |
2023-01-05 |
江苏先声药业有限公司 |
Cd16抗体及其应用
|
|
EP4377352A2
(en)
|
2021-07-30 |
2024-06-05 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
|
US20240343803A1
(en)
|
2021-07-30 |
2024-10-17 |
Shandong Simcere Biopharmaceutical Co., Ltd. |
Anti-Pvrig/Anti-Tigit Bispecific Antibodies And Applications Thereof
|
|
WO2023057601A1
(en)
|
2021-10-06 |
2023-04-13 |
Biotalys NV |
Anti-fungal polypeptides
|
|
WO2023098846A1
(zh)
|
2021-12-03 |
2023-06-08 |
江苏先声药业有限公司 |
抗bcma纳米抗体及其应用
|
|
KR20240122867A
(ko)
|
2021-12-17 |
2024-08-13 |
아블린쓰 |
TCRαβ, CD33, 및 CD123을 표적화하는 면역글로불린 단일 가변 도메인을 포함하는 폴리펩티드
|
|
WO2023125888A1
(zh)
|
2021-12-31 |
2023-07-06 |
山东先声生物制药有限公司 |
一种gprc5d抗体及其应用
|
|
WO2023135198A1
(en)
|
2022-01-12 |
2023-07-20 |
Vib Vzw |
Human ntcp binders for therapeutic use and liver-specific targeted delivery
|
|
EP4473108A1
(en)
|
2022-02-02 |
2024-12-11 |
Biotalys NV |
Methods for genome editing
|
|
EP4476250A1
(en)
|
2022-02-07 |
2024-12-18 |
Vib Vzw |
Engineered stabilizing aglycosylated fc-regions
|
|
US20250235534A1
(en)
|
2022-04-13 |
2025-07-24 |
Vib Vzw |
An LTBR Agonist In Combination Therapy Against Cancer
|
|
WO2023213751A1
(en)
|
2022-05-02 |
2023-11-09 |
Umc Utrecht Holding B.V |
Single domain antibodies for the detection of plasmin-cleaved vwf
|
|
CA3249283A1
(en)
|
2022-05-18 |
2023-11-23 |
Vib Vzw |
BINDERS OF SARBECOVIRUS SPICULE S2 SUBUNITS
|
|
IL317463A
(en)
|
2022-06-06 |
2025-02-01 |
Shandong Simcere Biopharmaceutical Co Ltd |
Multispecific antibodies targeting BCMA, GPRC5D and T cells and their application
|
|
JP2025523630A
(ja)
|
2022-07-04 |
2025-07-23 |
ブイアイビー ブイゼットダブリュ |
血液－脳脊髄液関門通過抗体
|
|
EP4594348A1
(en)
|
2022-09-27 |
2025-08-06 |
Vib Vzw |
Antivirals against human parainfluenza virus
|
|
EP4605077A1
(en)
|
2022-10-18 |
2025-08-27 |
Confo Therapeutics N.V. |
Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders
|
|
EP4619156A1
(en)
|
2022-11-15 |
2025-09-24 |
Imec VZW |
Method and system for droplet manipulation
|
|
WO2024126805A1
(en)
|
2022-12-15 |
2024-06-20 |
Aarhus Universitet |
Synthetic activation of multimeric transmembrane receptors
|
|
EP4638735A1
(en)
|
2022-12-22 |
2025-10-29 |
Biotalys NV |
Methods for genome editing
|
|
US20260026500A1
(en)
|
2022-12-29 |
2026-01-29 |
Biotalys NV |
Agrochemical compositions
|
|
EP4642232A1
(en)
|
2022-12-30 |
2025-11-05 |
Biotalys NV |
Self-emulsifiable concentrate
|
|
WO2024141641A2
(en)
|
2022-12-30 |
2024-07-04 |
Biotalys NV |
Secretion signals
|
|
WO2024141645A1
(en)
|
2022-12-30 |
2024-07-04 |
Biotalys N.V. |
Agglomerate
|
|
EP4655324A1
(en)
|
2023-01-27 |
2025-12-03 |
Vib Vzw |
Cd163-binding conjugates
|
|
WO2024156881A1
(en)
|
2023-01-27 |
2024-08-02 |
Vib Vzw |
CD8b-BINDING POLYPEPTIDES
|
|
WO2024165710A1
(en)
|
2023-02-09 |
2024-08-15 |
Seni-Preps B.V. |
Immunoglobulin single variable domains that inhibit urease and use thereof
|
|
WO2024175787A1
(en)
|
2023-02-24 |
2024-08-29 |
Vrije Universiteit Brussel |
Anti-inflammatory pannexin 1 channel inhibitors
|
|
EP4680624A1
(en)
|
2023-03-14 |
2026-01-21 |
Aarhus Universitet |
Genetically altered nfr5 receptor kinases
|
|
AU2024243709A1
(en)
|
2023-04-03 |
2025-11-06 |
Katholieke Universiteit Leuven |
Blood-brain barrier crossing antibodies
|
|
EP4709753A1
(en)
|
2023-05-11 |
2026-03-18 |
Vib Vzw |
Slc4a4/nbce1 inhibitors
|
|
CN121604979A
(zh)
|
2023-05-23 |
2026-03-03 |
上海联进生物科技有限公司 |
包含效应分子的pd-l1和trop-2靶向缀合物及其用途
|
|
WO2024261344A1
(en)
|
2023-06-23 |
2024-12-26 |
Vib Vzw |
Novel binders targeting the multi-drug resistant pathogen acinetobacter baumannii
|
|
EP4483951A1
(en)
|
2023-06-30 |
2025-01-01 |
Université de Liège |
Single-domain antibody for inhibition of neutrophil elastase activity
|
|
NL2036011B1
(en)
|
2023-10-12 |
2025-04-30 |
Synapse Res Institute |
Molecules for reversing anti-coagulant activity of direct oral anticoagulants
|
|
WO2025093683A1
(en)
|
2023-11-03 |
2025-05-08 |
Neuvasq Biotechnologies Sa |
Wnt7 signaling agonists
|
|
WO2025109176A1
(en)
|
2023-11-22 |
2025-05-30 |
Exevir Bio Bv |
Optimized sarbecovirus spike s2 subunit binders and compositions comprising the same
|
|
WO2025125577A1
(en)
|
2023-12-14 |
2025-06-19 |
Vib Vzw |
Antibodies against influenza b virus
|
|
US12378306B2
(en)
|
2023-12-22 |
2025-08-05 |
Biotalys NV |
Anti-fungal VHH antibodies
|
|
WO2025154056A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect cda nanobodies and uses thereof
|
|
WO2025154058A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect hsp70 nanobodies and uses thereof
|
|
WO2025181155A1
(en)
|
2024-02-26 |
2025-09-04 |
Vib Vzw |
Human beta-glucocerebrosidase binders and uses thereof
|
|
WO2025196308A1
(en)
|
2024-03-22 |
2025-09-25 |
Vib Vzw |
Means and methods for displaying fc-containing proteins on cells and selection thereof
|
|
WO2025219231A1
(en)
|
2024-04-15 |
2025-10-23 |
Vib Vzw |
Computer-implemented means and methods for the de novo design of antibodies targeting a specific epitope
|
|
WO2025238157A1
(en)
|
2024-05-15 |
2025-11-20 |
Katholieke Universiteit Leuven |
Multispecific binding agent suitable for use in cancer immune therapy
|
|
WO2026008665A1
(en)
|
2024-07-01 |
2026-01-08 |
Vib Vzw |
Binders of the pd-1•pd-l1 complex and their use
|
|
WO2026008785A1
(en)
|
2024-07-03 |
2026-01-08 |
Biotalys NV |
Agrochemical compositions
|
|
WO2026027659A1
(en)
|
2024-07-31 |
2026-02-05 |
Seni-Preps B.V. |
Improved immunoglobulin single variable domains that inhibit urease and use thereof
|
|
WO2026068859A1
(en)
|
2024-09-30 |
2026-04-02 |
Université Libre de Bruxelles |
Wnt signaling agonist molecules in the treatment of a bone-related disease or disorder
|